XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.7.0.1

The Business (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2017
The Business [Abstract] |
Summary of Principles of Consolidation | The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly-owned and partially-owned subsidiaries and affiliates as listed below. All intercompany activities have been eliminated in consolidation.
Entity |  | Percentage of Ownership |  | Location
Caladrius Biosciences, Inc. |  | 100% |  | United States of America
Amorcyte, LLC |  | 100% |  | United States of America
NeoStem Oncology, LLC |  | 100% |  | United States of America
Athelos Corporation (1) |  | 98.4% |  | United States of America
PCT, LLC, a Caladrius Company (2) |  | 80.1% |  | United States of America
NeoStem Family Storage, LLC (2) |  | 80.1% |  | United States of America
PCT Allendale, LLC (2) |  | 80.1% |  | United States of America
_________________________________________________________________ (1) As of March 31, 2017, Becton Dickinson's ownership interest was 1.6%. (2) As of March 31, 2017, Hitachi's ownership interest was 19.9% (see Note 3).

X
- Definition The Business [Abstract] + References No definition available. + Details
Name: | clbs_BusinessAbstract
Namespace Prefix: | clbs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Subsidiary [Table Text Block] + References No definition available. + Details
Name: | clbs_SubsidiaryTableTextBlock
Namespace Prefix: | clbs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration